Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

November 1, 2018

Study Completion Date

April 30, 2019

Conditions

Diabetic Macular Edema

Interventions

DRUG

dexamethasone implant

intravitreal dexamethasone implant injections in vitrectomized patients with DME

DRUG

Ranibizumab

intravitreal ranibizumab injections in vitrectomized patients with DME

Trial Locations (1)

Far Eastern Memorial Hospital, New Taipei City

All Listed Sponsors

lead

Far Eastern Memorial Hospital

OTHER

NCT04089605 - Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema | Biotech Hunter | Biotech Hunter